DEA And Marijuana Rescheduling Opponents File Final Briefs In Hearing Ahead Of Judge’s Decision
The Drug Enforcement Administration (DEA) is reiterating that it doesn’t believe a recently published federal watchdog agency report that found “gaps” in the government’s process for evaluating controlled substances undermines the Trump administration’s proposal to reschedule marijuana. But anti-rescheduling parties that are participating in a hearing on the reform say that procedural shortcomings have irreparably […]
Marijuana Opponents And Pharma Company File Brief Asking Court To Block Trump’s Hemp CBD Medicare Coverage Plan
A coalition of anti-marijuana groups and a cannabis-focused biopharmaceutical corporation have filed a new brief in their lawsuit challenging the Trump administration’s initiative to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. In May, Judge Trevor N. McFadden dismissed the challenge to the Centers for Medicare & Medicaid Services […]